J. Christopher Naftzger Arbutus Biopharma Corp (ABUS) insider trading activity

J. Christopher Naftzger is General Counsel and CCO of Arbutus Biopharma Corp. Currently has a direct ownership of 95,100 shares of ABUS, which is worth approximately $305,271. The most recent transaction as insider was on Feb 01, 2024, when has been sold 95,100 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 95.1K

0% 3M change

n/a 12M change

Total Value Held $305,271

J. Christopher Naftzger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Feb 01 2024	BUY Grant, award, or other acquisition	-	95,100 Added 50.0%	95,100 Common Shares

Also insider at

NBRV

Nabriva Therapeutics plc Healthcare

General Counsel and Corp Sec

JCN